Antiaging Effects of Mannose-6-Phosphate through Enhanced Mitochondrial Function and Collagen Remodeling Authors: Muniba Munir, Mengxin Zhang, Shahin Shah Khan, Lin Wu, Jun Wei, Hao Yin, Qi Zhou, Yian Zeng, Peng Shu, Luo Liu Published: 2026 ABSTRACT Aging is closely linked to mitochondrial dysfunction and the deterioration of the extracellular matrix (ECM), especially collagen. Mannose-6-phosphate (M6P), a naturally occurring glycolytic intermediate, has gained attention as a bioactive compound with potential antiaging benefits, modulating cellular metabolism. This study investigates the role of M6P in mitochondrial activity, oxidative stress, autophagy, and collagen remodeling. In vitro experiments with human keratinocytes and dermal fibroblasts revealed that M6P treatment significantly increased ATP, NADH, and NAD+ levels, thereby enhancing mitochondrial function and reversing UV-induced mitochondrial damage. Additionally, M6P promoted mitophagy and reduced the level of intracellular oxidative stress by 82%, indicating its antioxidant properties. Transcriptomic analysis showed that M6P up-regulated genes are involved in collagen synthesis and DNA repair, contributing to cellular defense against UV damage. Furthermore, a clinical trial was conducted at Zhejiang Xiaoshan Hospital with 36 healthy female participants over 56 days to test the effect, which further confirmed the improvements in skin firmness, elasticity, and wrinkle reduction following the use of the M6P antiaging cream. Overall, M6P appeared as a promising candidate for antiaging, which supports mitochondrial health, reduces oxidative damage, and promotes collagen regeneration. Introduction The skin, being the largest organ of the human body, acts as the first defense line against the external environment. Among the many stressors it faces, ultraviolet (UV) radiation is one of the most harmful. It can trigger oxidative damage, disrupt normal cellular functions, and accelerate the visible signs of skin aging. UVB radiation mainly causes oxidative stress, mitochondrial dysfunction, and degradation of the extracellular matrix (ECM), which results in the appearance of wrinkles, reduced elasticity, and hyperpigmentation. Notably, UVA radiation is known to penetrate the deepest layers of the dermis, producing enormous doses of reactive oxygen species (ROS). These free radicals directly damage DNA, proteins, and lipids. While UVB induces DNA lesions such as cyclobutane pyrimidine dimers (CPDs). Mitochondria are the major source of intracellular ROS, while also being the primary target of oxidative damage. UV radiation provokes swelling, fragmentation, and mutations in the mitochondrial DNA (mtDNA). Damaged mitochondria generate a higher level of ROS and comparatively less ATP, which leads to mitochondrial dysfunction, apoptosis, and cellular senescence. This cycle results in the progressive buildup of old (senescent) cells, ultimately driving the extrinsic skin aging process. − Aging is a continuous biological process that further leads to the decline of normal skin physiology and function. The process reduces the production of collagen in adult skin due to a decline in enzymes involved in the collagen post-translational modification. As a result, the skin’s extracellular matrix gradually deteriorates because the collagen scaffold becomes weaker and less stable. Furthermore, aging is marked by a gradual loss of cellular efficiency and an increased risk of disease. One of the major contributors to this decline is mitochondrial dysfunction. Under normal conditions, mitochondria generate ATP through oxidative phosphorylation, but this energy-producing process also creates reactive oxygen species (ROS). Higher ROS levels damage mitochondrial DNA, proteins, and membranes, which ultimately speeds up cellular aging and tissue deterioration. To maintain mitochondrial quality, cells rely on mitophagy, a selective form of autophagy that removes defective mitochondria and adjusts their number according to energy demand. As we grow, this mitochondrial clearance process becomes less efficient, allowing dysfunctional mitochondria to build up in the cells. This imbalance reduces ATP production, increases oxidative stress, and gradually contributes to tissue deterioration. , Additionally, enhancing mitophagy has recently emerged as a promising strategy to counteract aging by promoting the removal of damaged mitochondria and maintaining cellular health. Recent studies show that restoring mitochondrial health improves energy metabolism, reduces oxidative stress, and supports muscle health in elderly individuals. , The energy-producing organelles/powerhouse of the cell, mitochondria, are highly vulnerable to the harmful effects of UV, due to which cellular energy homeostasis is also disrupted. Therefore, mechanisms that improve mitochondrial functioning and reduce oxidative stress are of great interest in dermatological studies. M6P is a naturally occurring derivative of sugars that has recently been identified as a potential therapeutic agent because of its ability to influence cellular energy metabolism as well as promote tissue repair. Previous studies indicated that the M6P pathway can control mitochondrial viability and autophagy mechanisms that are essential for the homeostasis of the cell and elimination of abnormal organelles. , It is well-known that M6P, as a key glycolytic intermediate, participates in cellular energy metabolism and extracellular vesicle metabolic regulation by fueling glycolysis to generate adenosine triphosphate (ATP), which serves as the core energy source for cellular activities and further enhances global cellular metabolism.Thus, M6P and its complexes have been widely recognized as a promising candidate with a positive regulatory effect on the biomechanical characteristics of the skin, including elasticity and firmness.The biological activity of M6P was examined using different in vitro and ex vivo models so that we can illustrate the biological pathways through which M6P can deliver its potential antiaging effect on the skin. Recent research has ascertained its efficacy on the biomechanical properties of the skin through clinical studies. M6P is a major element in cellular energy provision and metabolism, specifically in the spheres of lysosomal protein targeting and glucose processes, a major intermediate in the mannose metabolic pathway, and is also a signal to transport specific proteins to lysosomes. Nevertheless, the mechanism of action behind its protective activity against skin damage induced by UV has not been fully characterized. Herein, this study aims to elucidate the multifaceted roles of M6P in regulating mitochondrial dynamics and restoring cellular balance by enhancing energy metabolism and activating repair mechanisms in skin cells. It highlights the interplay among M6P, mitochondrial quality control, and energy homeostasis, emphasizing how their combined effects contribute to antiaging processes. Materials and Methods Materials The materials utilized in this study include an ATP and NADPH kit (Beyotime), 4% paraformaldehyde (Thermo Fisher), an ADP-Ribosylation Factor ARF1/ARF3/ARF5/ARF6 monoclonal antibody (MA3-060, Thermo Fisher), a MitoProbe JC-1 staining kit (Thermo Fisher), DCFH-DA probe (Sigma-Aldrich), an ABclonal mRNA-seq Lib Prep Kit (ABclonal, China), and the TRIzol RNA extraction reagent (Thermo Fisher). The normal human dermal fibroblasts (NHDFs) and human immortalized keratinocytes (HaCaT) obtained from Sigma-Aldrich were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco), followed by the addition of 10% fetal bovine serum (FBS, Gibco) and incubated at 37 °C in a humidified environment containing 5% CO2. Cells were subcultured twice prior to the experiments to ensure their stability. Testing the Role of M6P in Cellular Energy Metabolism and Mitochondrial Function For the quantification of ATP, NADPH, and ATP synthase levels, fibroblasts were plated within 6-well plates (5 × 104 cells per well) and incubated overnight at 37 °C with 5% CO2. The working solutions of the test substance M6P (0.5–1.25%) were prepared. When the cell density in the 6-well plates reached 40–60%, UVA stimulation was applied. Following stimulation, 2 mL of test substance M6P (0.5–1.25%) was added to each well and incubated at 37 °C with 5% CO2 for 24 h. After 24 h of incubation, the cells were lysed, and the cell culture supernatant was collected to quantify the ATP and NADPH levels using the ATP and NADPH kit (Beyotime), and chemiluminescence was measured under a microplate reader (BioTek Synergy H1). The cell slides were fixed with 4% paraformaldehyde and incubated with the ADP-Ribosylation Factor ARF1/ARF3/ARF5/ARF6 monoclonal antibody (MA3-060, Thermo Fisher) to measure ATP synthase levels using fluorescence microscopy. Further, the HaCaT cells were transfected with a mCherry-FiNad probe to assess whether M6P has certain antiaging effects by comparing the fluorescence ratio changes of the probes before and after M6P treatment in response to the effects of M6P on NAD+. HaCaT-mCherry-FiNad cell lines were treated with 0.5%, 1%, and 1.5% M6P for 24 h. mCherry-cpYFP was used as a control probe for mCherry-FiNad, which had no response to NAD+, to calibrate nonspecific changes caused by pH perturbation. When the NAD+ content in cells increases, the mCherry-FiNad probe 488-channel fluorescence becomes stronger, and the 561-channel fluorescence remains unchanged at the ratio (F488/561), which detects the changes of the NAD+ content in cells. To observe real-time dynamics of NADH/NAD+, the SoNar fluorescent probe was transfected into HaCaT cells. A 96-well fluorescence image-specific microplate was cultured and treated with varying concentrations of M6P (0.5% and 1%) for different time intervals (5, 10, and 30 min) before microplate detection. The ratios of the fluorescence (F405/F488) were measured with the help of the confocal microscope. When the cellular NADH content was elevated, the SoNar probe 405-channel fluorescence became stronger, and the 488-channel fluorescence became weaker. However, in the cases where the cellular NAD+ content was elevated, the SoNar probe 405-channel fluorescence remained unchanged, and the 488-channel fluorescence was stronger. Mitochondrial Membrane Potential (MMP) HaCaT cells (5 × 104 cells per well) were plated in 24-well plates and incubated at 37 °C and 5% CO2 for 24 h. The normal control group, a baseline reference, represented the normal HaCaT cells with no injury and no treatment. Further, the model control group underwent irradiation using a Philips TL20W/12RS UVB lamp tube (main emission peak 312 nm), at an irradiation intensity of 0.4 mW/cm2 for 100 s to achieve a target irradiation dose of 40 mJ/cm2 with no M6P treatment applied, to establish a skin injury model for comparison with the sample group to confirm that any observed improvement is indeed due to M6P and no other factors. While the sample group underwent irradiation with 40 mJ/cm2 UVB for 100 s, the M6P sample was administered to evaluate the efficacy of M6P in injury models. All experimental groups were then treated with complete culture medium and continued to cultivate at 37 °C and 5% CO2 for 24 ± 2 h. Later, the cells were stained using a MitoProbe JC-1 staining kit (Thermo Fisher) following the kit protocol and observed under a fluorescence microscope. The fluorescence intensity (S) of each group was quantified by ImageJ analysis software, which quantifies fluorescence intensity by calculating the gray value of each pixel within an image. Fluorescence images are composed of pixels whose brightness corresponds directly to the fluorescence signal detected by the microscope. After splitting the red and green channels, ImageJ measures the mean gray value of each channel across the entire field. The red/green ratio (R/G), calculated as red mean intensity divided by green mean intensity, reflects mitochondrial membrane potential because JC-1 aggregates emit red fluorescence at high membrane potential and monomers emit green fluorescence at low membrane potential. Since no region of interest (ROI) was selected in this experiment, the entire field of each image was analyzed to avoid selection bias and ensure consistency across samples, and the rate of decline in mitochondrial membrane potential was calculated as: Rateofmembranepotentialdecline(%)=S(Greenfluorescenceintensity)S(Redfluorescenceintensity)×100% Three independent images were analyzed per group (n = 3). The resulting values were exported and analyzed statistically with GraphPad Prism to generate graphs. Assessment of Antioxidant Activity and Autophagy-Modulating Effects of M6P Reactive Oxygen Species (ROS) Measurement The four experimental groups were assigned to the NHDF. There was no UVB induction or treatment of the blank control group. The negative control group was treated with the UVB (300 mJ/cm2) only. The positive control group was irradiated with UVB (300 mJ/cm2) and treated with vitamin C (100 μg/mL) and vitamin E (7 μg/mL). While the treatment group was subjected to M6P at different concentrations of 3%, 1.5%, and 0.75% under the same UVB induction (300 mJ/cm2). Following treatment, all experimental groups continued to grow for 24 h, and the intracellular ROS content was assessed by 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA). DCFH-DA probe master mix was diluted with serum-free culture medium at a ratio of 1:1000 to achieve a final concentration of 10 μmol/L. 500 μL of the diluted DCFH-DA probe was added to each well, respectively, and incubated at 37 °C for 30 min. After that, the cells were washed 4 times with serum-free DMEM to clear off the excess probe, and ROS-induced fluorescence was detected using a fluorescence microscope with an excitation wavelength of 488 nm. Mitophagy Analysis The working solution of the test substances was prepared according to the experimental groups. When the cell density in the 6-well plate reached 40–60%, the cells were treated with H2O2 for 2 h to induce oxidative stress. After induction, 2 mL of the corresponding working solution was added to each well in triplicate. In the blank control group and the negative control group, 2 mL of complete culture medium was added to each well, whereas in the sample groups, 2 mL of culture medium containing the indicated concentration of M6P was added and incubated at 37 °C and 5% CO2 for 24 h. These stimulation and administration steps were repeated three times. After incubation, the cells were plated into confocal microdishes and incubated for 24 h to allow attachment. Following incubation, cells were washed with PBS and fixed using 4% paraformaldehyde for 10 min. After fixation, cells were incubated for 30 min with Mito-Tracker Green fluorescent dye to observe mitochondrial morphology, then washed and blocked. The immunofluorescence of E3 ubiquitin ligase Parkin was detected using the anti-ALX4 antibody (HPA001903, Sigma-Aldrich). Images were recorded with a confocal microscope, and colocalization fluorescence signals of red and green fluorescence were analyzed using ImageJ (FIJI) image processing software. Transcriptomic Analysis of Human Fibroblasts NHDFs (3 × 105 cells/3 mL in each well) were divided into four experimental groups. The negative control group was cultured in 1% FBS-DMEM without being exposed to UV and without being treated with M6P. The effect of M6P alone was tested by placing the non-UV test group under normal culture conditions in 1% FBS-DMEM with 0.1% M6P. To develop a UV-induced cellular damage model (model group, M) was irradiated with UV and then cultured in DMEM with 1% FBS. The model treatment group (M + 0.1) was subjected to UV light and subsequently to 0.1% M6P in 1% FBS-DMEM to evaluate the protective or regulatory properties of M6P in the presence of UV induced stress conditions. Three biological repeats were set up in each group and incubated for 48 h. After incubation, cells were washed with PBS twice. To extract total RNA, NHDFs were subjected to the TRIzol RNA extraction reagent (Thermo Fisher) as per the manufacturer’s protocol. The concentration and purity of RNA were determined by the NanoDrop 2000/2000c spectrophotometer (Thermo Fisher), and the integrity of the RNA and possible genomic DNA contamination were determined using agarose gel electrophoresis. The ABclonal mRNA-seq Lib Prep Kit (ABclonal, China) was used to construct paired-end sequencing libraries, with the main steps being mRNA enrichment, A-tailing, end repair, adapter ligation, fragment size selection, mRNA A-tailing, and PCR amplification. The quality of libraries and the size distribution of fragments were determined by the Agilent 4150 system. The MGISEQ-T7 genetic sequencer was then used to conduct high-throughput transcriptome sequencing to produce high-quality mRNA-seq data at Tianjin Nohe Medical Laboratory Co, Ltd. Sample correlation and principal component analysis were performed to test the reliability of experiments and the rationality of sample selection. Differentially expressed genes were detected by using DESeq Statistical analysis to summarize the number of up-regulated and down-regulated genes in each comparison group. The volcano map of differentially expressed genes was drawn using R. Enrichment analysis of genes using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Reactome pathway analysis was conducted to find out the significantly enriched biological functions and signaling pathways. Reactome pathway enrichment analysis, GO, and KEGG enrichment analysis were conducted to define significantly enriched biological processes and signaling pathways. Moreover, gene set enrichment analysis (GSEA) was performed to evaluate the coordinated changes in the expression at the pathway level. The fold-change value was used to rank all of the detected genes to visualize the global expression patterns between the two sample groups and to assess the role of an individual gene among the observed phenotypic differences. Gene sets of known biological functions in the GO, KEGG, and Reactome databases were predefined to identify whether genes in each functional category were significantly overrepresented at the top or bottom of the ranked list of genes. This strategy made it possible to test the joint effect of simultaneous changes in the expression of each gene set on the phenotypic variation. Translational Evaluation of M6P by Skin Modeling and Clinical Trial Ex Vivo Efficacy Test of M6P in the Skin Explant Model To assess the ex vivo efficacy of M6P, human female skin explant tissues were obtained from Zhejiang Xiaoshan Hospital, with ethical approval granted by the institutional review board (approval number EC-P-2025021101). The tissues were disinfected with 75% alcohol. Subcutaneous tissue and fat were carefully removed, and the skin was sectioned for a gas–liquid culture, which was maintained at 37 °C with 5% CO2. The modeling and treatment process was initiated on day 2 of explant culture by changing the culture medium. The normal control group was untreated, whereas the model control group was exposed to UV irradiation (10 J/cm2 UVA +80 mJ/cm2 UVB). The sample group received the same UV irradiation treatment, followed by M6P administration (both surface and liquid-phase application). Later after two consecutive days of irradiation, the skin explants were further cultured with M6P for 2 days, 5% CO2 at 37 °C. Furthermore, several 1 mm tissue pieces were placed in 1.5 mL centrifuge tubes containing fixatives to prepare them to undergo transmission electron microscopy (TEM) and incubated overnight at 4 °C. According to the experimental plan of transmission electron microscopy, resin blocks were prepared through dehydration and osmotic polymerization as follows: the samples were initially fixed in 3.5% glutaraldehyde at room temperature (1 h) and then incubated at 4 °C for 12–24 h. After fixation, the samples were fixed with 1% osmium tetroxide and then dried in a series of ethanol (30–100%). The dehydrated samples were infiltrated with a series of propylene oxide-epoxy resins (1:1 → 1:2 → pure resin) and polymerized at 60 °C for 48 h. The embedded samples were further sliced into ultrathin slices (60–70 nm) and stained with uranyl acetate and lead citrate. Lastly, to observe the tissue ultrastructure, transmission electron microscopy of the tissue was carried out with a Hitachi HT-7800 TEM at 80 kV. The dermal permeability of the M6P was tested by the Franz diffusion cell method using a SYSTEM 918-12 dry-heated automated transdermal diffusion sampling system (LOGAN, USA). The sample solution was prepared by weighing 0.15 g of M6P and dissolving it in 5 mL phosphate-buffered saline (PBS) and further diluted (1:10) with PBS to obtain 0.3% (w/v) M6P solution. A Franz diffusion cell was used, where a 3 M transdermal diffusion membrane was placed between the receptor and donor chambers with a quantitative diffusion ring. This was followed by the addition of 0.3% M6P solution to the donor chamber, and no air was injected at the interface of the membranes. The 250 μL samples were taken at predetermined time points (1, 2, 4, 8, 12, and 24 h) and replaced with an equal volume of fresh PBS to ensure that the volume remained constant. HPLC-UV was used to determine the concentration of the M6P in the samples, and the cumulative permeation (mg/cm2) was plotted to quantify the transdermal flux with time. Clinical Efficacy of M6P Antiaging Cream This study employs a 3% cream formula containing C16–24 stearate as the main emulsifier and C9–12 alkyl esters as the lipid-phase constituent in the base cream. The polymeric thickening system based on cross-linked acrylic/C10–30 alkyl alcohol acrylic polymers was used to maintain the viscosity and structural stability. To ensure hydration and maintain phase uniformity, butanediol was added as a polyol humectant. The active ingredients were 3% sodium mannan phosphate and a mannose mixture to optimize the functional activity in the formulation. All components were homogenized under controlled emulsification conditions to make a stable and reproducible topical preparation for experimental evaluation. To check the efficacy of this formulation, a general clinical trial was conducted at Zhejiang Xiaoshan Hospital in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Zhejiang Xiaoshan Hospital (Approval No. EC-P-2025021101; Date of Approval: 11 February, 2025). Written informed consent was obtained from all subjects before enrollment. The trial enrolled 36 healthy Chinese female subjects, aged 25–60 years old, with sagging skin, lack of elasticity, visible eye wrinkles, eye wrinkles grade 3–5, and at least one visible pigmentation spot with an ITA° difference of more than 10° from the surrounding neighboring skin and a diameter of not less than 3 mm. A pea-sized amount of this M6P antiaging cream was gently applied on the cleansed face twice a day, patting gently until fully absorbed, accompanied by a sunscreen product. Further, ultrascan image recordings were made using Ultrascan UC 22 (C&K company, Germany) to capture baseline images before applying the M6P antiaging cream (Day 0) and after 14 days, 28 days, and 56 days of continuous use, for comparative analysis. Skin firmness, skin elasticity, and skin dermal layer thickness of the subjects’ test areas were tested at the same time point (day 14, 28, and 56). Additionally, the subjects were evaluated by a dermatologist’s visual assessment of skin, and statistical analysis was performed to compare the results. Statistical Analysis All the results are presented as mean ± standard deviation (SD). Each experiment had at least three independent replicates to guarantee the reliability and reproducibility of the results. Statistical analysis was performed by using SPSS software. An independent sample’s t-test was used to compare two groups, and the level of significance was defined as α = 0.05. Statistically significant differences were found at p < 0.05, and p-values <0.01 and 0.001 were highly significant, when compared with the model control group. Results and Discussion M6P Improves Cellular Energy Supply and Empowers Mitochondria In this study, a UV-induced cell injury model was developed as a negative control to simulate the major characteristics of extrinsic skin aging, where external UV radiation causes oxidative stress and mitochondrial dysfunction. This process eventually contributes to a vicious cycle of self-amplifying effects between outside and inside damage. − M6P treatment demonstrated high cell survival rates (95–98%) at lower concentrations (0.08–2.65 mg/L) as shown in Table S1. These results show that M6P is cytocompatible under low concentrations, and high concentrations can decrease cell viability. The role of M6P in cellular energy metabolism and cellular protection against oxidative stress was further explored by measuring the levels of ATP, NADPH, and ATP synthase in UV-induced damaged fibroblasts (Figure A–C, I). Compared with the UV-induced negative control group, M6P treatment significantly increased the total ATP content by 230% (Figure A), NADPH level by 165% (Figure B), and ATP synthase expression level by 1750% (Figure C). Consistently, the fluorescence imaging results of ATP synthase (Figure I) further confirmed that treatment with M6P (0.5–1.25%) significantly increased mitochondrial ATP generation synthesis in damaged cells. These findings affirm that M6P improves mitochondrial function, supporting its role as a metabolic regulator. Previous studies have demonstrated that succinate dehydrogenase complex assembly factor 1 (SDHAF) is involved in the regulation of metabolic efficiency through the production of ATP in the mitochondria, which further supports the notion that age-related deterioration can be slowed down by increasing energy output. In addition, the NADPH-elevating impact of M6P is similar to findings indicating that cytoplasmic and mitochondrial NADPH systems play a central role in alleviating oxidative stress throughout aging. Our results suggest that M6P improves mitochondrial function, which is crucial for cellular energy homeostasis. Mitochondrial damage is among the major causes of skin aging, especially during UV-damage. The beneficial effect of M6P on mitochondrial activity indirectly facilitates the synthesis of collagen by increasing energy availability, which further facilitates the synthesis and remodeling of collagen, an essential part of the extracellular matrix (ECM). Eventually, it results in enhanced skin elasticity and wrinkle reduction. Role of M6P in cellular energy metabolism and mitochondrial function. (A–C) Quantitative analysis of ATP, NADPH, and ATP reflecting cellular energy metabolism under control, UV-exposed, and M6P-treated conditions. (D) Representative fluorescence images of HaCaT cells with the mCherry-FiNad biosensor, showing the variation of intracellular NAD+ levels after exposure to various concentrations of M6P. (E) Quantification of HaCaT-mCherry-FiNad fluorescence intensity showing that M6P promotes NAD+. Quantitative analysis of the ratio was performed on n = 45 (Control), n = 42 (0.5% M6P), n = 48 (1% M6P), and n = 43 (1.5% M6P) individual cells from three independent experiments (Scale bar, 10 μm). (F–H) Fluorescence images and corresponding quantification analysis using Sonar and iNAPC biosensors to detect real-time dynamic changes in the NADH/NAD+ ratio in cells. Quantitative analysis was performed on n = 45 (Ctrl, 0 min), n = 42 (0.5% M6P, 30 min), and n = 43 (1% M6P, 30 min) individual cells from three independent experiments. Scale bar, 10 μm. (I) Fluorescence images showing the ATP synthase content in different experimental groups. BC = blank control, NC = negative control, PC = positive control, and the data is presented as mean ± SD (*p < 0.05, **p < 0.01, ##p < 0.01, ***p < 0.001). In addition, the mCherry-FiNad fluorescence probe showed that M6P increases NAD+ levels, which are crucial to activating sirtuins, a family of enzymes involved in antiaging pathways (Figure D). As shown in Figure E, M6P causes an NAD+ increase in a dose-dependent manner. Further, Sonar and iNAPC biosensor-based real-time monitoring of the NADH/NAD+ ratio showed a significant change in the ratio with an initial increase at 5 min, a decrease at 10 min, and a recovery at 30 min (Figure F–H). The fluctuations could be as a result of pH imbalance in the cells, which was automatically controlled with time. The NADH/NAD+ ratio stabilization upon 30 min reveals an increased energy metabolism in the cell and its shift to a more reduced state, which is favorable for energy storage and sirtuin activity. This is similar to the NADH/NAD+ tolerance observed in senescent stem cells, where reestablished redox homeostasis is a predictor of antiaging. Thus, by stabilizing the NADH/NAD+ ratio, M6P enhances energy metabolism and increases the activity of the NAD+-dependent enzymes, including sirtuins, which is consistent with prior studies that show that the NAD+ metabolism is one of the important mediators of cellular senescence. M6P is an intermediate of glycolysis and a vital pathway for producing cellular energy. M6P increases mitochondrial activity by increasing the ATP level, which is essential in energy metabolism and antioxidant defense. We found that M6P not only increased the ATP level but also improved the NADH/NAD+ ratio, which is key to mitochondrial bioenergetics and the prevention of oxidative stresses. The mitochondrial membrane potential (ΔΨm) was determined using JC-1 staining to evaluate the effect of M6P on mitochondrial viability. The M6P produced a significant increase in ΔΨm of UV-damaged HaCaT cells (Figure A), which was measured by a high ratio of red/green fluorescence in M6P-treated cells compared to the control group, indicating improved mitochondrial viability (Figure B). This finding aligns with the well-established role of mitochondrial membrane potential (ΔΨm) as a core determinant of cellular ATP production, and M6P-mediated restoration of ΔΨm was consistent with previous reports linking sustained mitochondrial membrane potential to inhibited mitochondrial degradation and inflammation under stress conditions. , Notably, M6P not only repaired UV-induced ΔΨm impairment in skin cells but also ameliorated age-associated mitochondrial dysfunction, a protective effect consistent with mitochondrial metabolic regulation in other aging tissues. Overall, these findings support the hypothesis that M6P improves mitochondrial function, thereby offering potential antiaging benefits through enhanced cellular energy metabolism, reduced oxidative stress, and improved ECM integrity. Impact of M6P on oxidative stress and mitochondrial autophagy in vitro. (A) Fluorescence images indicating the mitochondrial membrane potential assessed by JC-1 staining. (B) Quantification of the JC-1 red/green fluorescence intensity ratio. (C) Quantification of M6P’s antioxidant capacity corresponding to the ROS content results analysis. (D) Representative fluorescence images showing the reduction in ROS content by M6P compared with the negative control group. Quantitative analysis was performed on n = 3 independent biological replicates, with 3 technical replicates per group in each experiment, and 5 random fields of view quantified per well. (E) Representative confocal immunofluorescence images of the mitochondrial morphology (green) and E3 ubiquitin ligase Parkin (red) in cells. Nuclei are stained in blue. The yellow/orange signal denotes the colocalization between Parkin and mitochondria. (F) Quantification of Parkin-mitochondria colocalization by Pearson’s correlation coefficient (Rr). BC = blank control, NC = negative control, PC = positive control, and the data is presented as mean ± SD (n = 3; *p < 0.05, **p < 0.01, ##p < 0.01). M6P Modulates Oxidative Stress and Mitochondrial Autophagy The ROS assays demonstrated that M6P dramatically decreased intracellular ROS build-up in UVB-stressed fibroblasts by 82% (Figure C), which is powerful evidence of its antioxidant defense. Figure D presents the fluorescence images of intracellular ROS measured by using the DCFH-DA probe to assess oxidative stress levels under different conditions. UV radiation, a key extrinsic driver of skin aging, which causes oxidative stress, results in macromolecular damage, pro-inflammatory signaling, and dermal extracellular matrix remodeling. Mitochondrial dysfunction is a major intracellular source of excessive ROS under UV damage. M6P exhibited a potent ROS-suppressive effect in UVB-stressed skin cells, which aligns with its antioxidant and photoprotective activity and supports the hypothesis that M6P mitigates UVB-induced oxidative stress via mitophagy, a critical pathway in alleviating photoaging-related oxidative damage. These results demonstrate that M6P exerts its antioxidant properties by coupling ROS detoxification with the modulation of mitochondrial activity. Figure E further demonstrates that M6P induces mitophagy, as evidenced by the colocalization of Parkin with mitochondria in immunofluorescence images, reflecting the clearance of dysfunctional mitochondria. Parkin is an E3 ubiquitin ligase protein that helps to remove damaged mitochondria into an autophagosome and promotes their degradation via the process of selective autophagy. This is in line with previous studies that indicated that mitophagy is crucial in clearing dysfunctional mitochondria, thus avoiding the buildup of ROS. Such selective degradation of impaired mitochondria supports the hypothesis that cellular energy homeostasis is maintained by a balance between mitochondrial biogenesis and mitophagy. Recent studies have also shown that mitophagy prevents the cytosolic accumulation of mitochondrial DNA, thus inhibiting inflammation associated with aging and the chronic cGAS-STING signaling pathway. Quantitative colocalization analysis revealed that the average Pearson’s correlation coefficient (Rr) decreased from 0.68 in the blank control to 0.47 in the negative control but was significantly increased to 0.59 with 1% M6P treatment, representing 25.53% improvement over the negative control (Figure F). A higher Rr indicates stronger colocalization between E3 ubiquitin ligase Parkin and mitochondria, suggesting that M6P plays a significant role in promoting mitochondrial autophagy. Just like metformin, which has been claimed to normalize mitochondrial function and induce autophagy to counteract inflammation in aging, M6P seems to couple mitochondrial clearance with improved bioenergetics. It further justifies its use as a therapeutic agent to mitigate mitochondrial dysfunction in aging. Transcriptomic Evidence of Antiaging Action and Transdermal Permeability of M6P mRNA-seq showed that M6P exerts antiaging effects by increasing the expression of genes related tECM processes, especially those related to epithelial cell migration, collagen synthesis, ECM binding, hyaluronic acid biosynthesis, nociception, and other biological processes (Figure A). Notably, M6P preferentially increased the expression of genes related to collagen biosynthesis (e.g., COL6A2, COL17A1), integrin-related genes (ITGA10), and DNA repair (e.g., CDC family genes), which are involved in protecting UV-induced damage (Figure S4). These results agree with the idea that the functionality of the mitochondrial respiratory chain contributes to the integrity of the ECM. The disruption of ECM cell mechanobiology that occurs in fibro-aging can therefore be reversed by the treatment with M6P. M6P produces a dual protective effect against UV-induced dermal degradation by reinforcing collagen gene expression and also inducing DNA repair. Figures S1–S7 represent the gene regulation of M6P under UV irradiation, indicating that M6P upregulates DNA double-strand damage repair genes and several pathways involved in ATP synthesis, ECM assembly, epithelial cell proliferation, and collagen metabolism, including PI3K-AKT, calcium, TGF-β, IL-4/IL-13, and interferon signaling pathways. Transcriptomic analysis and ultrastructural characterization of extracellular matrix remodeling. (A) mRNA-seq shows that M6P preferentially upregulates the expression of collagen biosynthesis genes (such as COL6A2, COL17A1) and DNA repair genes (such as CDC family genes), which are involved in protection against UV-induced damage. Larger and red colored circles represent a greater influence on genes. (B–E) Dermal permeability of M6P measured using the Franz diffusion cell technique. The results demonstrate the time-dependent behavior of transdermal diffusion of M6P under the specified experimental conditions. (F) Transmission electron microscopy (TEM) images showing: (A) Collagen fiber orientation and (B) ECM structure showing that collagen organization is modified by M6P treatment. In addition to the above molecular regulatory effects, the dermal permeability of M6P was determined using the Franz diffusion cell technique. As shown in Figure B–E, the permeability of the 3 M transdermal diffusion membrane reached about 80% in 1 h, and the cumulative penetration remained almost unchanged after 12 h. Over a 24 h period, the cumulative transmission volume of M6P was 1.36 mg (Figure C), and the cumulative transmission rate was 97.57% (Figure E). These results indicated that M6P has a high rate of transdermal absorption. Exogenous M6P is taken into the cells through special transporters, which help it to penetrate the cytoplasm. These findings indicate that M6P is effectively absorbed in the skin and reaching the deeper dermal layers can affect mitochondrial activity and collagen production. Although the expression of transporters has a major influence on the efficiency of M6P uptake, the exact transporters and their contribution to the observed results have not been determined yet and require further investigation. Validation of M6P in the Skin Model and Clinical Studies The TEM analysis revealed that M6P treatment reversed the effect of UV damage and rebuilt collagen fiber structure and density in the skin (Figure F), aligning with prior studies on collagen repair and skin elasticity. M6P successfully rejuvenated the integrity of destroyed collagen fibers, making them more tightly packed and arranged in order (Figure F­(A)). As shown in Figure F­(B), it also reduced the breakage of collagen fibers, increasing the number of collagen fibers, and the diameter distribution was more uniform when compared to the model control group (irradiated). In comparison to UV-only models, fibers were more continuous and less fragmented. This finding resonates with clinical findings that collagen breakdown is the cause of dermal atrophy and wrinkling. Notably, it confirms recent findings that ECM integrity is closely linked to mitochondrial homeostasis. Thus, M6P functions at both the metabolic and structural levels of skin aging by restoring mitochondrial activity and collagen remodeling. Based on the above results, a topical M6P cream was tested in a 56 day human trial (n = 36) to determine whether the biological effects of M6P translate into any quantifiable cosmetic benefits. The skin biomechanics were measured in terms of a suction-based Cutometer method that quantifies skin deformation (distensibility/firmness) and recoil (elastic recovery) based on time strain curves and obtained parameters. Compared to baseline (D0), the indices of firmness R0 and F4 were reduced after 56 days (Figure A, B). R0 represents the maximum deformation under suction, and smaller values usually indicate decreased distensibility and increased mechanical deformation. Similarly, protocols designed to apply repeated cyclic procedures have an area-based parameter F4 to indicate viscoelastic skin firmness (i.e., resistance to suction across cycles), and a lower value generally depicts greater firmness in cosmetic efficacy testing. Clinical trial results representing the M6P’s firming and antiwrinkle efficacy. (A, B) Showing skin firming effect R0 and F4 (C–F). Demonstrating improvement in skin elasticity parameters Q1, R2, R5, and F3/F4 at baseline (D0) and after 14 (D14), 28 (D28), and 56 days (D56) of treatment. (G) Representative ultrascan images of different volunteers depicting improved dermal thickness at D28, and D56 of M6P antiaging cream application as compared to the baseline D0. The data is presented as mean ± SD (n = 36; ***p < 0.001). At the same time, several end points related to elasticity (Q1, R2, R5, and F3/F4 ratio) increased at D56 (Figure C–F). Herein, the relevant elasticity parameters are defined as follows: R0 refers to skin immediate extensibility, representing the initial deformation capacity of the skin under external force; F4 denotes skin viscoelastic firmness, reflecting the overall stiffness and compactness of the skin; Q1 is the skin elastic recovery coefficient; R2 represents gross elasticity/viscoelastic recovery; R5 stands for net elasticity; and F3/F4 ratio is the skin elastic firmness. An increase in the values of R2 and R5 is usually indicative of high recoil efficiency, whereas an increase in the values of Q1 is indicative of high recovery behavior, which is consistent with increased skin elasticity and tightening. This fact is further confirmed by an increase in the F3/F4 ratio, contributing to the enhanced resilience and decreased fatigue-like behavior. These biomechanical changes were in line with structural and topographical improvements observed in the skin. Epidermal thickness was measured using high-frequency ultrasonography (22 MHz) (Figure G), and quantitative analysis (Table S2) at D0, D28, and D56 of M6P cream application revealed an elevation of dermal-layer thickness, which indicated remodeling or densification of the dermal compartment. Wrinkle microtopography was evaluated with PRIMOS-CR, a fringe-projection 3D system which is often utilized in measuring wrinkle depth, volume, and microrelief on the surface. Findings showed that there was a reduction in wrinkle length, area, volume, and count (Figure S8). All these directional changes,(i) decreased distensibility (R0/F4), (ii) enhanced elastic recoil (R2/R5/Q1 and F3/F4), (iii) enhanced dermal thickness (as shown in ultrascan images), and (iv) reduced wrinkle load, are indicative of the potential of M6P to improve clinically relevant hallmarks of skin aging over 56 days. However, the agreement of the independent modalities: biomechanical analysis, imaging, and 3D wrinkle topography, supports the conclusion that M6P enhances functional and morphological improvements, indicating its therapeutic potential beyond the variability of single measurement. These findings are parallel to the topical NAD+ precursors improving skin aging parameters. Hence, the extrapolation of in vitro and in vivo results to clinical benefits highlights the potential of M6P as a cosmeceutical active ingredient. Its multifunctional aspects in energy metabolism, autophagy, antioxidant defense, and collagen remodeling confer a holistic antiaging mechanism. Conclusions This study concludes that M6P effectively reduces oxidative stress and improves collagen structure, leading to visible antiaging effects on the clinical level. M6P induces autophagy and enhances mitochondrial function, and it also has a good safety profile and high permeability, which makes it a prospective ingredient in dermatological and cosmetic products. The expression of M6P transporters is crucial for its cellular uptake and efficacy. Although the exact transporter proteins were not studied in the present study, it is known that the cellular uptake of glycolytic intermediates, including M6P, occurs via specific transporter proteins. Further research into the identification and characterization of these transporters will give a better understanding of the mechanistic pathways through which M6P produces its antiaging properties, especially in relation to mitochondrial activity and collagen production. However, more research is required to understand the long-term outcomes of M6P, optimize its dosage, and find out the possible synergy between M6P and other active compounds to improve its use in regenerative medicine and cosmeceuticals. Supplementary Material